Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc.
XNYS:HIMS
39.83
3.72%

Ask
$40.10 - 450.00
Bid
$38.00 - 1,000.00
Low
$38.52
High
$39.87
Open
$38.9
Prev Close
$38.4
52W High
72.98
52W Low
23.97
Volume
9363512
Avg Vol (3m)
21428408.4
Float
204664043.06
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 8011
Sector: Health Services
Industry: Medical/Nursing Services
Date Listed: 01/21/2021
Primary Exchange: XNYS

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Phone: 415-851-0195
Address: 2269 Chestnut St
Address 2: #523
City: San Francisco
State: CA
Postal Code: 94123
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
1,637
P/E (TTM)
73.507118
P/B (TTM)
15.569100
EPS
0.06
Round Lot
100
Composit FIGI
BBG00Q53VYM7
Share Class FIGI
BBG00Q5LQWK9
Share Class Shares Outstanding
217.64M
Weighted Shares Outstanding
227.65M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own HIMS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.